• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Theses
  • Research Data
  • Projects
  • Organizations
  • Researchers
  • More
  • Collections
  • Statistics
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Cefepime is efficacious against penicillin- and quinolone-resistant pneumococci in experimental meningitis
 

Cefepime is efficacious against penicillin- and quinolone-resistant pneumococci in experimental meningitis

Options
  • Details
  • Files
BORIS DOI
10.7892/boris.25734
Publisher DOI
10.1093/jac/49.2.327
PubMed ID
11815575
Description
In experimental rabbit meningitis, cefepime given at a dose of 100 mg/kg was associated with concentrations in the cerebrospinal fluid of between 5.3 and 10 mg/L and a bactericidal activity of -0.61 +/- 0.24 Delta log(10) cfu/mL x h, similar to the standard regimen of ceftriaxone combined with vancomycin (-0.58 +/- 0.14 Delta log(10) cfu/mL x h) in the treatment of meningitis due to a penicillin- and quinolone-resistant pneumococcal mutant strain (MIC 4 mg/L). Compared with the penicillin-resistant parental strain, the penicillin- and quinolone-resistant mutant was killed more slowly by cefepime and ceftriaxone in time-killing assays in vitro over 8 h.
Date of Publication
2002
Publication Type
Article
Language(s)
en
Contributor(s)
Cottagnoud, P
Acosta, F
Cottagnoud, M
Täuber, Martin G.
Institut für Infektionskrankheiten
Additional Credits
Institut für Infektionskrankheiten
Series
Journal of antimicrobial chemotherapy
Publisher
Oxford University Press
ISSN
0305-7453
ISBN
11815575
Access(Rights)
open.access
Show full item
BORIS Portal
Bern Open Repository and Information System
Build: dd892c [ 9.04. 8:30]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
  • Audiovisual Material
  • Software & other digital items
  • Events
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo